|
Market Closed -
Sao Paulo
11:48:35 14/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 68.74 BRL | +29.23% |
|
+3.23% | -3.06% |
| Market Cap | 80.23B 420B 69.3B 65.12B 59.22B 111B 7,672B 113B 763B 298B 3,842B 301B 295B 12,767B | P/E 2026 * |
18.6x | P/E 2027 * | 15.9x |
|---|---|---|---|---|---|
| Enterprise Value | 73.36B 384B 63.36B 59.54B 54.15B 102B 7,015B 103B 698B 273B 3,513B 275B 269B 11,674B | EV / Sales 2026 * |
4.33x | EV / Sales 2027 * | 3.8x |
| Free-Float |
71.07% | Yield 2026 * |
0.49% | Yield 2027 * | 0.55% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +29.23% | ||
| 1 week | +3.23% | ||
| Current month | +6.96% | ||
| 1 month | +22.16% | ||
| 3 months | +15.61% | ||
| 6 months | -0.56% | ||
| Current year | -3.06% |
| 1 week | 65.01 |  | 70.28 |
| 1 month | 54.19 | | 70.28 |
| Current year | 50 | | 73.16 |
| 1 year | 49.24 | | 73.33 |
| 3 years | 44.82 | | 111.72 |
| 5 years | 44.82 | | 111.72 |
| 10 years | 18.16 | | 111.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +29.23% | +3.23% | - | - | 80.23B | |
| -0.31% | +2.44% | +38.43% | -0.30% | 80.23B | |
| -1.02% | -0.51% | -2.54% | +26.80% | 50.64B | |
| -3.10% | -4.84% | +10.29% | +158.34% | 46.87B | |
| -0.74% | +3.26% | -49.51% | -49.96% | 46.34B | |
| -0.39% | +0.91% | +51.39% | -22.35% | 31B | |
| -0.52% | +7.01% | +125.98% | -34.32% | 25.28B | |
| -0.30% | -0.33% | +38.24% | +83.70% | 24.36B | |
| -1.42% | -1.11% | -3.79% | +190.40% | 20.81B | |
| -1.83% | -2.82% | +60.85% | +107.54% | 16.08B | |
| Average | +1.96% | +1.44% | +29.93% | +51.09% | 37.96B | |
| Weighted average by Cap. | +4.74% | +1.13% | +22.69% | +36.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.92B 88.56B 14.62B 13.74B 12.49B 23.49B 1,618B 23.87B 161B 62.93B 810B 63.54B 62.16B 2,693B | 18.34B 95.98B 15.84B 14.89B 13.54B 25.45B 1,754B 25.87B 174B 68.2B 878B 68.87B 67.37B 2,919B |
| Net income | 4.69B 24.57B 4.05B 3.81B 3.47B 6.52B 449B 6.62B 44.65B 17.46B 225B 17.63B 17.24B 747B | 5.35B 27.98B 4.62B 4.34B 3.95B 7.42B 511B 7.54B 50.85B 19.88B 256B 20.08B 19.64B 851B |
| Net Debt | -6.87B -35.94B -5.93B -5.57B -5.07B -9.53B -657B -9.69B -65.32B -25.54B -329B -25.79B -25.23B -1,093B | -10.55B -55.22B -9.12B -8.57B -7.79B -14.65B -1,009B -14.89B -100B -39.24B -505B -39.62B -38.76B -1,679B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | BRL 68.74 | -1.31% | 38 |
| 13/08/26 | BRL 69.65 | +1.12% | 1,775 |
| 12/08/26 | BRL 68.88 | -0.40% | 74 |
| 11/08/26 | BRL 69.16 | +0.92% | 428 |
| 10/08/26 | BRL 68.53 | +2.91% | 1,556 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
- REGN34 Stock
Select your edition
All financial news and data tailored to specific country editions
